Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Nov 13, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intercept Pharmaceuticals, Inc.
| -33.60K |
$19.00 | -$638,362.00 | -100.00% |
0
|
Nov 8
| |||||||
Quince Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 23
| |||||||
Quince Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Intercept Pharmaceuticals, Inc.
| 8.11K |
—
|
—
| +31.82% | 33.6K |
May 24
| |||||||
Intercept Pharmaceuticals, Inc.
| 7.74K |
—
|
—
| +43.59% | 25.49K |
May 25
| |||||||
Intercept Pharmaceuticals, Inc.
| 7.03K |
—
|
—
| +65.56% | 17.75K |
May 27
| |||||||
Intercept Pharmaceuticals, Inc.
| 1.59K |
—
|
—
| +17.48% | 10.72K |
May 28
| |||||||
Intercept Pharmaceuticals, Inc.
| 1.57K |
—
|
—
| +20.78% | 9.13K |
Jun 20
| |||||||
Intercept Pharmaceuticals, Inc.
| 1.2K |
$83.50 | $100,200.00 | +18.88% | 7.56K |
May 14
| |||||||
Intercept Pharmaceuticals, Inc.
| 1.79K |
—
|
—
| +39.11% | 6.36K |
Jun 20
| |||||||
Intercept Pharmaceuticals Inc
| 1.42K |
—
|
—
| +45.23% | 4.57K |
Jun 27
| |||||||
Intercept Pharmaceuticals Inc
| 1.2K |
—
|
—
| +62.00% | 3.15K |
Jul 19
| |||||||
Intercept Pharmaceuticals Inc
| 650 |
—
|
—
| +50.31% | 1.94K |
Nov 24
| |||||||
Intercept Pharmaceuticals Inc
| 800 |
$139.86 | $111,888.00 | +162.60% | 1.29K |
Dec 15
| |||||||
Intercept Pharmaceuticals Inc
| 452 |
—
|
—
| +1,130.00% | 492 |
Jul 17
| |||||||
Intercept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||